Boehringer Ingelheim and Click Therapeutics expand collaboration to develop digital therapeutics for schizophrenia

LG Chem inks deal with Innovent Biologics for gout treatment candidate

LG Chem will receive totaling up to $95.5 million for the China rights

Balaxi conducts groundbreaking for its Rs 85 crore Hyderabad manufacturing facility

The investment will enable the company to enter European markets as well as enhance margins in current markets

AstraZeneca India appoints Dr. Sanjeev Panchal as Country President & MD

Sanjeev is currently the Country President for AstraZeneca Malaysia

High demand leaves Ozempic compensating for Wegovy’s supply shortage: GlobalData

Merck to present data from Its hematology portfolio ASH meeting

Presentations include new data on investigational medicines – favezelimab (MK-4280), zilovertamab vedotin (MK-2140) and nemtabrutinib – as well as KEYTRUDA (pembrolizumab) in multiple blood cancers

Orchid Pharma launches Rs. 500 Cr QIP programme

With this QIP placement, the Dhanuka group, which took over the company in 2018, is also meeting its mandatory obligation to dilute 15 percent stake in the company by March 2023

Merck to acquire Imago BioSciences for $1.35 bn

Acquisition expands Merck’s growing hematology portfolio

Strides receives USFDA approval for Potassium Chloride Oral Solution

The approval further strengthens the Potassium Chloride franchise for the company.

Biocon Q2FY23 net profit slips 10% to Rs 168 Cr; Revenue up 26%